EP Patent

EP2807157A1 — 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

Assigned to Novartis AG · Expires 2014-12-03 · 11y expired

What this patent protects

The invention relates to a compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

USPTO Abstract

The invention relates to a compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Drugs covered by this patent

Patent Metadata

Patent number
EP2807157A1
Jurisdiction
EP
Classification
—
Expires
2014-12-03
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.